Blueprint Medicines ROA - Return on Assets 2014-2024 | BPMC

Blueprint Medicines return on assets for the quarter ending September 30, 2024 was -11.4.

  • Blueprint Medicines average return on assets for 2023 was -44.93, a 11.71% decline from 2022.
  • Blueprint Medicines average return on assets for 2022 was -50.89, a 698.9% decline from 2021.
  • Blueprint Medicines average return on assets for 2021 was -6.37, a 32.88% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Blueprint Medicines ROA - Return on Assets 2014-2024 | BPMC

  • Blueprint Medicines average return on assets for 2023 was -44.93, a 11.71% decline from 2022.
  • Blueprint Medicines average return on assets for 2022 was -50.89, a 698.9% decline from 2021.
  • Blueprint Medicines average return on assets for 2021 was -6.37, a 32.88% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.